News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference


2/4/2014 7:57:58 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Peter Suzdak, PhD, the Company’s Chief Executive Officer, will present a company update at the 16th Annual BIO CEO & Investor Conference being held in New York City, NY. The presentation will be on Monday, February 10, 2014 at 2:30pm EST. A webcast of the presentation will be available on www.rexahn.com.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES